IDStewardship
JUNE 21, 2022
In this article a pharmacist with significant experience in the area of finance identifies and discusses five common financial mistakes to avoid as a pharmacist. . Authored By: Timothy Ulbrich, PharmD. Co-Founder and CEO of Your Financial Pharmacist (YFP). Article posted 21 June 2022. While financial mistakes may seem inevitable, some do not have to be.
pharmaphorum
JUNE 21, 2022
Armed with new phase 3 data, AstraZeneca is preparing to file for regulatory approval of eplontersen, an antisense drug for one of the complications of the disease transthyretin amyloidosis (ATTR) it licensed from Ionis in a $3.6 billion deal last year. Eplontersen – previously known as IONIS-TTR-LRX – is designed to switch off the production of transthyretin (TTR), a protein which builds up in the disease to toxic levels causing heart problems (cardiomyopathy) and nerve damage (polyneuropathy).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JUNE 21, 2022
If new restrictions are placed on the FDAâs Accelerated Approval pathway, as many as two thirds of the treatments that use this pathway would never reach patients, according to research released at the BIO International Convention last week.
pharmaphorum
JUNE 21, 2022
While proponents argue waiving IP on COVID-19 vaccines would better enable low- and middle-income countries to inoculate their populations, the pharma industry has called the proposals “unnecessary and harmful to innovation”. Proposals to waive COVID-19 product patents have been described as “political posturing” and an “answer to a problem that does not exist”.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 21, 2022
Two medical professionals reveal what factors into intensive chemotherapy consideration and common toxicities found when undergoing treatment.
pharmaphorum
JUNE 21, 2022
Alzheimer’s disease could be diagnosed from a single MRI brain scan, according to a new study by Imperial College London. Using machine learning technology, researchers were able to examine structural features of the brain, including regions that are not traditionally associated with Alzheimer’s. The simplicity of this process, scientists suggest, could aid clinicians in identifying the disease at an early stage when it can be challenging to diagnose.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
indispensable health
JUNE 21, 2022
Do you know a Pharmacist with a North Dakota License? Our journey to Fargo, North Dakota began when one of our clients forwarded an email to our team asking if there was anyone who knew a pharmacist with a North Dakota license. Innocently, and perhaps naively, Todd Raehtz, President of Indispensable Health , replied to the email that he had personally received the multistate pharmacist passport in response to the COVID-19 pandemic and North Dakota was among the participating states.
Pharmaceutical Commerce
JUNE 21, 2022
When choosing a 3PL whether for a new product launch in the near future or re re-evaluating your current situation, certain key considerations must be addressed before you make a final decision.
pharmaphorum
JUNE 21, 2022
Integrated Care Systems (ICSs) – 42 partnerships of health and care organisations who will plan and deliver more joined-up services for their locality in England from 1 July 2022 – will touch on every issue that is shaping healthcare today. “A lot of things are happening in the environment right now and all of the key issues at the national level are relevant at the sub-national – ICS – level.
PharmaVoice
JUNE 21, 2022
Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
JUNE 21, 2022
uMotif and ClinOne announced at the 2022 DIA Global Annual Meeting that they have partnered to deliver an integrated solution for eCOA and eConsent in trials.
PharmaVoice
JUNE 21, 2022
In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.
Pharmaceutical Commerce
JUNE 21, 2022
When choosing a 3PL whether for a new product launch in the near future or re re-evaluating your current situation, certain key considerations must be addressed before you make a final decision.
PharmaVoice
JUNE 21, 2022
Regulatory experts weigh in on ways to enhance the controversial drug approval approach.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
JUNE 21, 2022
Pre-clinical screening technology could increase cancer test numbers by 50 times
Pharmaceutical Commerce
JUNE 21, 2022
CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment.
Pharma Manufacturing
JUNE 21, 2022
Did short-term solutions for COVID-19 stifle long-term mRNA success?
Pharmaceutical Commerce
JUNE 21, 2022
Features an ATP solution to allow for efficiency.
Pharma Times
JUNE 21, 2022
Eplontersen significantly improved patient-reported quality of life following successful research
Expert insights. Personalized for you.
130 
Let's personalize your content